The Amsterdam appeals court decided not to force a 12-year-old boy to undergo chemotherapy for a brain tumor in a ruling on Tuesday. A child psychiatrist judged that the boy is capable of making the decision to refuse treatment, and his father was not able to sufficiently raise doubts about this finding, the court ruled, RTL Nieuws reports.
Twelve year old David from Noord-Holland does not have to undergo chemotherapy treatment for his brain tumor if he does not want to, the court in Alkmaar ruled on Friday. David's father turned to court in an effort to force his son to get treatment. With chemotherapy, the boy has 80 percent chance of survival, without his chances are 50 percent, the Telegraaf reports.
On Tuesday the court in Alkmaar handled a case of a father trying to force his 12-year-old son to be treated for his brain cancer. The case was filed by the father against the foundation for Youth- and Family Protectors, who is supervising the boy's treatment, ANP reports.
A commonly used chemotherapy drug can temporarily make patients' fingerprints unreadable, according to a study by Eramsus MC and the police in The Hague
A revolutionary stem cell treatment in Sweden forever changed the live of MS patient Boaz Spermon. After two months of treatment in a Swedish hospital, the 32 year old Den Bosch man was able to walk out of the hospital. Walk out, without the wheelchair he'd been bound to for eight months.
The Erasmus Medical Center in Rotterdam has launched an experiment in which cancer patients receive their chemotherapy treatments at home, instead of in the hospital.
Cancer patient Nol van Bekhoven was told that he had until the Spring to live according to Dutch doctors. He has survived past Spring and well into Summer, and is even tumor-free after going to Belgium for treatment, the Algemeen Dagblad reports.
1 out of 5 women with breast cancer and clean lymph nodes in the armpit do not need chemotherapy after surgery. Therefore, they should all be offered a genetic tumor test, according to Sabine Linn, professor and medical oncologist at the Antoni van Leeuwenhoek Hospital. She is involved in the study of the test.